> University Academic Staffback
A photo of Dr CHAN Pak Hei, Michael
Dr CHAN Pak Hei, Michael
Specialist in Cardiology, Gleneagles Hong Kong Hospital
Clinical Assistant Professor, Department of Medicine, The University of Hong Kong
MD (HK), MBBS (HK), MRCP (UK), FRCP (Edin), FRCP (Glasg), FHKCP, FHKAM (Medicine), FACC
an email logo
a telephone logo 2255-3879
a fax logo 2818-6304


Dr. Chan is the Clinical Assistant Professor in Cardiology of the University of Hong Kong and he is currently working in the Gleneagles Hong Kong Hospital. He received his medical degree and doctoral degree in medicine from the University of Hong Kong and is the fellow of the Hong Kong College of Cardiology, the Hong Kong College of Physicians, the Hong Kong Academy of Medicine, Royal College of Physicians of Edinburgh, Royal College of Physicians and Surgeons of Glasgow, and the American College of Cardiology. He has worked for more than 14 years in the Cardiology Division of Queen Mary Hospital.

His expertise includes percutaneous coronary intervention of complex coronary artery disease and minimally invasive trans-catheter valve therapies including trans-catheter aortic valve implantation and left atrial appendage occlusion. Dr. Chan has published over 60 peer-reviewed articles in major cardiology journals including JACC and Circulation.


Selected Publications

  1. Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW, Siu CW. Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017;135:110-112
  2. Chan PH, Huang D, Hai J, Li WH, Yin LX, Chan EW, Wong IC, Lau CP, Chiang CE, Zhu J, Tse HF, Siu CW. Stroke Prevention Using Dabigatran in the Very Elderly with Atrial Fibrillation. Heart Rhythm 2016;13:366-73
  3. Chan PH, Siu CW. Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation. J Am Coll Cardiol 2015;66:1310-1
  4. Chan PH, Hai J, Yeung CY, Lip GY, Lam KS, Tse HF, Siu CW. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. Europace 2016;18:665-71
  5. Chan PH, Wong CK, Poh YC, Pun L, Leung WW, Wong YF, Wong MM, Poh MZ, Chu DW, Siu CW. Diagnostic Performance of a Smartphone-Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting. J Am Heart Assoc 2016;5(7). pii: e003428
  6. Chan PH, Li WH, Hai JJ, Tse HF, Siu CW. Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease. PLoS One 2015;10:e0131479
  7. Chan PH, Huang D, Lau CP, Chan EW, Wong IC, Lip GY, Tse HF, Siu CW. Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range. Can J Cardiol 2016;32:1247.e15-1247.e21
  8. Alegria-Barrero E, Chan PH*, Foin N, et al. Concept of the central clip: when to use one or two MitraClips. EuroIntervention 2014;9:1217-24 (*co-first author)
  9. Chan PH, Di Mario C, Franzen O. Dissociation between anatomical and functional results after MitraClip implantation. Int J Cardiol 2012;155:175-6
  10. Chan PH, She HL, Alegria-Barrero E, et al. Real-World Experience of MitraClip for Treatment of Severe Mitral Regurgitation. Circ J 2012;76:2488-9
  11. Alegría-Barrero E, Chan PH, Di Mario C, et al. Tools and techniques: edge-to-edge percutaneous MitraClip implantation. EuroIntervention 2012;7:1476-8
  12. Alegria-Barrero E, Chan PH, Paulo M, et al. Edge-to-Edge Percutaneous Repair of Severe Mitral Regurgitation - state-of-the-art for Mitraclip implantation. Circ J 2012;76:801-8
  13. Chan PH, Di Mario C, Davies SW, et al. Transcatheter Aortic Valve Implantation in Degenerate Aortic Homograft Root Replacements. J Am Coll Cardiol 2011;58:1729-30
  14. Chan PH, Alegria-Barrero E, Foin N, et al. Extended use of the GuideLiner in complex coronary interventions. EuroIntervention 2015;11:325-35
  15. Viceconte N, Chan PH, Alegria-Barrero E, et al. Frequency domain optical coherence tomography for guidance of coronary stenting. Int J Cardiol 2013;166:722-8
  16. Chan PH, Alegria-Barrero E, Di Mario C. Tools and Techniques: Intravascular Ultrasound and Optical Coherence Tomography. EuroIntervention 2012;7:1343-1349
  17. Alegría-Barrero E, Foin N, Chan PH, et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention 2012;8:205-13

Grant Record

  1. Health and Medical Research Fund (HMRF) 2014 – Comparative Evaluation of Combined Coronary Computed Tomography Angiography and Myocardial Perfusion Versus Cardiac Magnetic Resonance Imaging Myocardial Perfusion for Diagnosis of Coronary Artery Disease (HKD $940,296)
  2. Health and Medical Research Fund (HMRF) 2016 – Prospective evaluation of the impact of Drug-Coated Balloon in the management of true coronary bifurcation disease (HKD $1,121,520)
  3. S.K. Yee Medical Foundation Grants 2015 – Provision of free non-vitamin K antagonist oral anticoagulants for poor and sick patients with atrial fibrillation who have high ischemic stroke risk (HKD $694,080)
  4. S.K. Yee Medical Foundation Grants 2015 – Free computed tomography coronary angiography for poor and sick patients to evaluate for coronary artery disease (HKD $480,000)
  5. S.K. Yee Medical Foundation Grants 2015 – Provision of free B-type natriuretic peptide testing for poor and sick patients with fluid overload to improve heart failure management (HKD $270,750)

Key Offices

  • Consultant, Department of Medicine, HKU-Shenzhen Hospital
  • Honorary Associate Consultant, Family Medicine & Public Health Care, HKEC
  • Council member, Institute of Cardiovascular Science and Medicine
  • Fellow, Hong Kong College of Cardiology